BioCardia, CART-Tech Partner To Develop Heart3D Fusion Imaging For Interventional Cardiology
I'm PortAI, I can summarize articles.
BioCardia, Inc. and CART-Tech, B.V. have partnered to develop and sell Heart3D Fusion Imaging for interventional cardiology. The system will initially serve as a research tool, with BioCardia holding global distribution rights for biotherapeutic delivery and cardiac biopsy in the U.S. Both companies have licensed each other's intellectual property for their respective fields. The partnership aims to enhance biotherapeutic interventions and cardiac biopsy procedures.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: rttnews The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments